JP2022545019A5 - - Google Patents
Info
- Publication number
- JP2022545019A5 JP2022545019A5 JP2022511322A JP2022511322A JP2022545019A5 JP 2022545019 A5 JP2022545019 A5 JP 2022545019A5 JP 2022511322 A JP2022511322 A JP 2022511322A JP 2022511322 A JP2022511322 A JP 2022511322A JP 2022545019 A5 JP2022545019 A5 JP 2022545019A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- dihydrothieno
- cyclopenta
- pyrazole
- indazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962891097P | 2019-08-23 | 2019-08-23 | |
| US62/891,097 | 2019-08-23 | ||
| PCT/US2020/047552 WO2021041276A1 (en) | 2019-08-23 | 2020-08-22 | Heterocyclic pyrazole derivatives as type iii receptor tyrosine kinase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022545019A JP2022545019A (ja) | 2022-10-24 |
| JP2022545019A5 true JP2022545019A5 (cg-RX-API-DMAC7.html) | 2023-08-18 |
| JP7651557B2 JP7651557B2 (ja) | 2025-03-26 |
Family
ID=74685735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022511322A Active JP7651557B2 (ja) | 2019-08-23 | 2020-08-22 | Iii型受容体チロシンキナーゼ阻害剤としてのヘテロ環式ピラゾール誘導体 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US12448394B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4017853A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7651557B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220051365A (cg-RX-API-DMAC7.html) |
| CN (1) | CN114502553B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020337883B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022003383A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3151821A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022002062A (cg-RX-API-DMAC7.html) |
| TW (1) | TWI759829B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021041276A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113278010A (zh) * | 2021-06-01 | 2021-08-20 | 中国科学院上海有机化学研究所 | 一类蛋白激酶降解剂及其用途 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003234567A1 (en) * | 2002-05-15 | 2003-12-02 | Janssen Pharmaceutica N.V. | N-substituted tricyclic 3-aminopyrazoles as pdfg receptor inhibitors |
| RU2425677C2 (ru) | 2005-01-21 | 2011-08-10 | Астекс Терапьютикс Лимитед | Соединения, предназначенные для использования в фармацевтике |
| EP1845974A1 (en) * | 2005-01-21 | 2007-10-24 | Astex Therapeutics Limited | Pharmaceutical compounds |
| BRPI0618011A2 (pt) * | 2005-10-28 | 2011-08-16 | Astrazeneca Ab | composto ou um sal farmaceuticamente aceitável do mesmo, processo para a preparação do mesmo, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, métodos para produzir um efeito anti-proliferativo e um efeito pró-apoptósico em um animal de sangue quente, para tratar doença e para produzir um efeito inibidor de jak em um animal de sangue quente |
| WO2008045627A2 (en) | 2006-10-06 | 2008-04-17 | Irm Llc | Protein kinase inhibitors and methods for using thereof |
| CA2686378C (en) * | 2007-05-04 | 2012-07-24 | Irm Llc | Pyrimidine derivatives and compositions as c-kit and pdgfr kinase inhibitors |
| CA2780892C (en) * | 2009-11-13 | 2017-02-14 | Genosco | Kinase inhibitors |
| GB201007286D0 (en) * | 2010-04-30 | 2010-06-16 | Astex Therapeutics Ltd | New compounds |
| UY33801A (es) | 2010-12-13 | 2013-06-28 | Array Biopharma Inc | COMPUESTOS SUSTITUIDOS DE N-(1H-INDAZOL-4IL)IMIDAZO[1,2-a]PIRIDIN-3-CARBOXAMIDA COMO INHIBIDORES DE LA TIROSINA QUINASA RECEPTORA DE TIPO III |
| WO2013142382A1 (en) * | 2012-03-22 | 2013-09-26 | Genosco | Substituted pyridopyrimidine compounds and their use as flt3 inhibitors |
| GB201205669D0 (en) * | 2012-03-30 | 2012-05-16 | Agency Science Tech & Res | Bicyclic heterocyclic derivatives as mnk2 and mnk2 modulators and uses thereof |
| US8853207B2 (en) * | 2012-04-12 | 2014-10-07 | Development Center For Biotechnology | Heterocyclic pyrazole compounds, method for preparing the same and use thereof |
| US9938273B2 (en) | 2015-12-07 | 2018-04-10 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
| CN119792569A (zh) | 2018-01-10 | 2025-04-11 | 财团法人生物技术开发中心 | 抗体protac偶联物 |
-
2020
- 2020-08-21 TW TW109128678A patent/TWI759829B/zh active
- 2020-08-22 US US17/636,116 patent/US12448394B2/en active Active
- 2020-08-22 CN CN202080059010.6A patent/CN114502553B/zh active Active
- 2020-08-22 CA CA3151821A patent/CA3151821A1/en active Pending
- 2020-08-22 WO PCT/US2020/047552 patent/WO2021041276A1/en not_active Ceased
- 2020-08-22 KR KR1020227009059A patent/KR20220051365A/ko active Pending
- 2020-08-22 AU AU2020337883A patent/AU2020337883B2/en active Active
- 2020-08-22 MX MX2022002062A patent/MX2022002062A/es unknown
- 2020-08-22 EP EP20856905.3A patent/EP4017853A4/en active Pending
- 2020-08-22 BR BR112022003383A patent/BR112022003383A2/pt unknown
- 2020-08-22 JP JP2022511322A patent/JP7651557B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022531801A5 (cg-RX-API-DMAC7.html) | ||
| JP2022531932A5 (cg-RX-API-DMAC7.html) | ||
| RU2009125897A (ru) | Ингибиторы фосфоинозитид-3-киназы и способы их применения | |
| TWI343383B (en) | Pyrazole derivatives and uses thereof | |
| ES2665036T3 (es) | Bencilinazoles sustituidos para su uso como inhibidores de BUB1 cinasa en el tratamiento de enfermedades hiperproliferativas | |
| AU2013207205B2 (en) | 4,4-disubstituted-1,4-dihydropyrimidines and the use thereof as medicaments for the treatment of Hepatitis B | |
| JP6231085B2 (ja) | アミノキナゾリン誘導体及びピリドピリミジン誘導体 | |
| US9290507B2 (en) | B-RAF kinase inhibitors | |
| HRP20231310T1 (hr) | Heteroarilaminopirimidin amidni inhibitori autofagije i postupci njihove primjene | |
| JP2010512338A5 (cg-RX-API-DMAC7.html) | ||
| JP2014531465A5 (cg-RX-API-DMAC7.html) | ||
| JP2013523884A5 (cg-RX-API-DMAC7.html) | ||
| JP2019535689A5 (cg-RX-API-DMAC7.html) | ||
| JP2013539777A5 (cg-RX-API-DMAC7.html) | ||
| RU2018134981A (ru) | Конъюгаты, содержащие ингибиторы RIPK2 | |
| KR20150131224A (ko) | 돌연변이 idh의 억제제로서의 3-피리미딘-4-일-옥사졸리딘-2-온 | |
| RU2016102137A (ru) | Первичные карбоксамиды в качестве ингибиторов bik | |
| JP2016522246A5 (cg-RX-API-DMAC7.html) | ||
| EP3157521A1 (en) | Substituted indazole compounds as irak4 inhibitors | |
| JP2016523911A5 (cg-RX-API-DMAC7.html) | ||
| DK3053923T3 (en) | TRIAZOLOPYRAZINE DERIVATIVES AS TYROSIN KINASE INHIBITORS | |
| RU2009105829A (ru) | СОЕДИНЕНИЯ И КОМПОЗИЦИИ В КАЧЕСТВЕ ИНГИБИТОРОВ ITPKb | |
| CA2899968A1 (en) | Substituted 2-aminopyridine protein kinase inhibitor | |
| JP2018507235A5 (cg-RX-API-DMAC7.html) | ||
| IL274198B2 (en) | Use of Nox inhibitors to treat cancer |